Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease

Documenti analoghi

• Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies
  di: Pegah Golabi, et al.
  Pubblicazione: (2024)
• Predicting Hepatic Decompensation in Patients With Metabolic Dysfunction Associated Steatotic Liver Disease‐Related Cirrhosis: The ABID‐LSM Model
  di: Luis Calzadilla Bertot, et al.
  Pubblicazione: (2025)
• Prevalence and Predictors of Suspected Metabolic Dysfunction‐Associated Steatotic Liver Disease in Adolescents in the United States
  di: Sheila L. Noon, et al.
  Pubblicazione: (2025)
• Social Determinants of Health in Metabolic Dysfunction‐Associated Steatotic Liver Disease and All‐Cause/Cause‐Specific Mortality
  di: Donghee Kim, et al.
  Pubblicazione: (2025)
• Association of High‐Sensitivity Troponins in Metabolic Dysfunction‐Associated Steatotic Liver Disease With All‐Cause and Cause‐Specific Mortality
  di: Donghee Kim, et al.
  Pubblicazione: (2025)